Finding – Page 15

Concentra’s Surprise Bid Disrupts Acelyrin-Alumis Merger Plans

8 months ago talkbio0Tagged Acelyrin, Alumis, biopharmaceutical industry, Concentra Biosciences, Disruption, M&A, Merger, Unsolicited Adverse Event

Concentra Biosciences, Acelyrin, Alumis, merger disruption, unsolicited offer, biopharmaceutical industry, M&A

Semaglutide Shows Promise in Reducing Alcohol Consumption, Small Study Reveals

9 months ago talkbio0Tagged addiction, Alcohol Use Disorder, Craving for alcohol, Glucagon-Like Peptide 1, semaglutide, Wegovy, Weight Loss Medication

semaglutide, Ozempic, Wegovy, alcohol use disorder, GLP-1 drugs, alcohol cravings, weight loss medication, addiction treatment

Vertex COO Stuart Arbuckle to Retire as Company Launches Groundbreaking Pain Drug Journavx

9 months ago talkbio0Tagged acute pain treatment, Approved, Arbuckle, Journavx, non-opioid pain medication, Retirement, Stuart Pharmaceuticals, United States Food and Drug Administration

Vertex Pharmaceuticals, Stuart Arbuckle, retirement, Journavx, non-opioid pain medication, FDA approval, acute pain treatment

Merck KGaA in Advanced Negotiations to Acquire SpringWorks Therapeutics

9 months ago talkbio0Tagged Acquisition, biopharmaceutical industry, cancer treatments, Does speak, Merck KGaA, Ogsiveo, SpringWorks

Merck KGaA, SpringWorks Therapeutics, acquisition talks, biopharmaceutical industry, rare diseases, cancer treatments, Ogsiveo

ViiV Healthcare’s Multifaceted Approach to Combating HIV in Black Communities

9 months ago talkbio0Tagged Black Populations, care activity, Community, community grants, HIV Prevention, Indication of (contextual qualifier), Risk, Social stigmata, ViiV Healthcare

ViiV Healthcare, HIV prevention, Black communities, Risk to Reasons, community grants, stigma reduction, education, access to care

Fourth Patient Receives Gene-Edited Pig Kidney in Groundbreaking Clinical Trial

9 months ago talkbio0Tagged Approved, Clinical Trials, eGenesis, Family suidae, Gene-Edited, Kidney, Kidney Failure, Chronic, Organ Shortage, United States Food and Drug Administration, United Therapeutics, Xenograft procedure

xenotransplantation, clinical trial, gene-edited pig kidney, FDA approval, United Therapeutics, eGenesis, end-stage renal disease, organ shortage

DOGE Access to Treasury Systems Restricted Amid Concerns Over CMS Scrutiny

9 months ago talkbio0Tagged concerns, DOGE, Elon, federal, Musk secretion from Musk Deer, Myasthenic Syndromes, Congenital, Patient location type - Department, payment, Privacy

Elon Musk, DOGE, Treasury Department, CMS, payment systems, privacy concerns, lawsuit, federal court order

Sanofi’s Beyfortus Achieves Blockbuster Status, Poised for Further Growth in US Market

9 months ago talkbio0Tagged Antibodies, Beyfortus, blockbuster sales, Growth, Infant, Market, Protection, Respiratory syncytial virus, sanofi, U.S.

Beyfortus, RSV antibody, Sanofi, blockbuster sales, US market growth, infant protection, respiratory syncytial virus

Inhibikase Halts Parkinson’s Drug Development After Phase II Failure, Shifts Focus to Pulmonary Arterial Hypertension

9 months ago talkbio0Tagged Clinical Failure, Drug Development, IkT-001Pro, Inhibikase, Parkinson 's disease, Phase 2 Clinical Trials, Pulmonary arterial hypertension, risvodetinib

Inhibikase Therapeutics, risvodetinib, Parkinson’s disease, Phase II trial, clinical failure, drug development, pulmonary arterial hypertension (PAH), IkT-001Pro

Veru’s Enobosarm Reduces Lean Mass Loss in Patients Taking Wegovy for Weight Reduction

9 months ago talkbio0Tagged Agonist, enobosarm, GLP-1 receptor, Lean mass preservation, Obesity, sarcopenic, semaglutide, Wegovy, Weight Loss

Enobosarm, Wegovy (semaglutide), Lean mass preservation, Weight loss, Sarcopenic obesity, GLP-1 receptor agonist